The fractalkine/CX3CR1 system regulates β cell function and insulin secretion

Cell

Volumn 153, Issue 2, 2013, Pages 413-425

  Lee, Yun Sok ^a   Morinaga, Hidetaka ^a   Kim, Jane J ^b   Lagakos, William ^a   Taylor, Susan ^c   Keshwani, Malik ^c   Perkins, Guy ^d   Dong, Hui ^a   Kayali, Ayse G ^b   Sweet, Ian R ^e   Olefsky, Jerrold ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c San Diego   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GLUCOSE; INSULIN;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FOOD INTAKE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRACELLULAR SIGNALING; LIPID DIET; LIVER WEIGHT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 84876213020     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.03.001     Document Type: Article

References (44)

1. T. Aoyama, S. Inokuchi, D.A. Brenner, and E. Seki CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice Hepatology 52 2010 1390 1400
2. S.A. Boehme, F.M. Lio, D. Maciejewski-Lenoir, K.B. Bacon, and P.J. Conlon The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia J. Immunol. 165 2000 397 403
3. A. Calabrese, M. Zhang, V. Serre-Beinier, D. Caton, C. Mas, L.S. Satin, and P. Meda Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells Diabetes 52 2003 417 424
4. A.E. Cardona, E.P. Pioro, M.E. Sasse, V. Kostenko, S.M. Cardona, I.M. Dijkstra, D. Huang, G. Kidd, S. Dombrowski, and R. Dutta Control of microglial neurotoxicity by the fractalkine receptor Nat. Neurosci. 9 2006 917 924
5. C.P. Carvalho, H.C. Barbosa, A. Britan, J.C. Santos-Silva, A.C. Boschero, P. Meda, and C.B. Collares-Buzato Beta cell coupling and connexin expression change during the functional maturation of rat pancreatic islets Diabetologia 53 2010 1428 1437
6. B. Chandrasekar, S. Mummidi, R.P. Perla, S. Bysani, N.O. Dulin, F. Liu, and P.C. Melby Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway Biochem. J. 373 2003 547 558
7. I.S. Cho, M. Jung, K.S. Kwon, E. Moon, J.H. Cho, K.H. Yoon, J.W. Kim, Y.D. Lee, S.S. Kim, and H. Suh-Kim Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription PLoS ONE 7 2012 e34860
8. C. Combadière, S. Potteaux, J.L. Gao, B. Esposito, S. Casanova, E.J. Lee, P. Debré, A. Tedgui, P.M. Murphy, and Z. Mallat Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice Circulation 107 2003 1009 1016
9. R.A. Defronzo Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 58 2009 773 795
10. D. Eberhard, M. Kragl, and E. Lammert 'Giving and taking': endothelial and beta-cells in the islets of Langerhans Trends Endocrinol. Metab. 21 2010 457 463
11. D. Favre, G. Niederhauser, D. Fahmi, V. Plaisance, S. Brajkovic, N. Beeler, F. Allagnat, J.A. Haefliger, R. Regazzi, G. Waeber, and A. Abderrahmani Role for inducible cAMP early repressor in promoting pancreatic beta cell dysfunction evoked by oxidative stress in human and rat islets Diabetologia 54 2011 2337 2346
12. A.M. Fong, S.M. Alam, T. Imai, B. Haribabu, and D.D. Patel CX3CR1 tyrosine sulfation enhances fractalkine-induced cell adhesion J. Biol. Chem. 277 2002 19418 19423
13. K.J. Garton, P.J. Gough, C.P. Blobel, G. Murphy, D.R. Greaves, P.J. Dempsey, and E.W. Raines Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) J. Biol. Chem. 276 2001 37993 38001
14. E. Giordano, V. Cirulli, D. Bosco, D. Rouiller, P. Halban, and P. Meda B-cell size influences glucose-stimulated insulin secretion Am. J. Physiol. 265 1993 C358 C364
15. C.A. Haskell, M.D. Cleary, and I.F. Charo Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation J. Biol. Chem. 274 1999 10053 10058
16. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J. Clin. Invest. 95 1995 2409 2415
17. C. Hundhausen, D. Misztela, T.A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, and V. Matthews The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion Blood 102 2003 1186 1195
18. M.A. Hussain, P.B. Daniel, and J.F. Habener Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells Diabetes 49 2000 1681 1690
19. T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, and O. Yoshie Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion Cell 91 1997 521 530
20. J.C. Jonas, A. Sharma, W. Hasenkamp, H. Ilkova, G. Patanè, R. Laybutt, S. Bonner-Weir, and G.C. Weir Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes J. Biol. Chem. 274 1999 14112 14121
21. A.G. Kayali, L.E. Flores, A.D. Lopez, B. Kutlu, E. Baetge, R. Kitamura, E. Hao, G.M. Beattie, and A. Hayek Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-producing beta-cells Diabetes 56 2007 703 708
22. B. Kutlu, A.G. Kayali, S. Jung, G. Parnaud, D. Baxter, G. Glusman, N. Goodman, L.A. Behie, A. Hayek, and L. Hood Meta-analysis of gene expression in human pancreatic islets after in vitro expansion Physiol. Genomics 39 2009 72 81
23. E. Lammert, G. Gu, M. McLaughlin, D. Brown, R. Brekken, L.C. Murtaugh, H.P. Gerber, N. Ferrara, and D.A. Melton Role of VEGF-A in vascularization of pancreatic islets Curr. Biol. 13 2003 1070 1074
24. Y.S. Lee, J.W. Choi, I. Hwang, J.W. Lee, J.H. Lee, A.Y. Kim, J.Y. Huh, Y.J. Koh, G.Y. Koh, and H.J. Son Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation J. Biol. Chem. 285 2010 22174 22185
25. Y.S. Lee, P. Li, J.Y. Huh, I.J. Hwang, M. Lu, J.I. Kim, M. Ham, S. Talukdar, A. Chen, and W.J. Lu Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance Diabetes 60 2011 2474 2483
26. P. Lesnik, C.A. Haskell, and I.F. Charo Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis J. Clin. Invest. 111 2003 333 340
27. A.D. Lucas, N. Chadwick, B.F. Warren, D.P. Jewell, S. Gordon, F. Powrie, and D.R. Greaves The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo Am. J. Pathol. 158 2001 855 866
28. N. MacLean, and R.F. Ogilvie Quantitative estimation of the pancreatic islet tissue in diabetic subjects Diabetes 4 1955 367 376
29. D.L. Morris, K.E. Oatmen, T. Wang, J.L. DelProposto, and C.N. Lumeng CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity Obesity (Silver Spring) 20 2012 1189 1199
30. J.M. Olefsky, and C.K. Glass Macrophages, inflammation, and insulin resistance Annu. Rev. Physiol. 72 2010 219 246
31. M. Pende, S.C. Kozma, M. Jaquet, V. Oorschot, R. Burcelin, Y. Le Marchand-Brustel, J. Klumperman, B. Thorens, and G. Thomas Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice Nature 408 2000 994 997
32. A. Pick, J. Clark, C. Kubstrup, M. Levisetti, W. Pugh, S. Bonner-Weir, and K.S. Polonsky Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat Diabetes 47 1998 358 364
33. M. Prentki, and C.J. Nolan Islet beta cell failure in type 2 diabetes J. Clin. Invest. 116 2006 1802 1812
34. J. Rahier, Y. Guiot, R.M. Goebbels, C. Sempoux, and J.C. Henquin Pancreatic beta-cell mass in European subjects with type 2 diabetes Diabetes Obes. Metab. 10 Suppl 4 2008 32 42
35. S. Seino, T. Shibasaki, and K. Minami Dynamics of insulin secretion and the clinical implications for obesity and diabetes J. Clin. Invest. 121 2011 2118 2125
36. R. Shah, C.C. Hinkle, J.F. Ferguson, N.N. Mehta, M. Li, L. Qu, Y. Lu, M.E. Putt, R.S. Ahima, and M.P. Reilly Fractalkine is a novel human adipochemokine associated with type 2 diabetes Diabetes 60 2011 1512 1518
37. D. Sirois-Gagnon, A. Chamberland, S. Perron, D. Brisson, D. Gaudet, and C. Laprise Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity Obesity (Silver Spring) 19 2011 222 227
38. S. Speier, A. Gjinovci, A. Charollais, P. Meda, and M. Rupnik Cx36-mediated coupling reduces beta-cell heterogeneity, confines the stimulating glucose concentration range, and affects insulin release kinetics Diabetes 56 2007 1078 1086
39. I.R. Sweet, D.L. Cook, E. DeJulio, A.R. Wallen, G. Khalil, J. Callis, and J. Reems Regulation of ATP/ADP in pancreatic islets Diabetes 53 2004 401 409
40. F. Tacke, D. Alvarez, T.J. Kaplan, C. Jakubzick, R. Spanbroek, J. Llodra, A. Garin, J. Liu, M. Mack, and N. van Rooijen Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques J. Clin. Invest. 117 2007 185 194
41. D. Teupser, S. Pavlides, M. Tan, J.C. Gutierrez-Ramos, R. Kolbeck, and J.L. Breslow Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root Proc. Natl. Acad. Sci. USA 101 2004 17795 17800
42. G.C. Weir, and S. Bonner-Weir Five stages of evolving beta-cell dysfunction during progression to diabetes Diabetes 53 Suppl 3 2004 S16 S21
43. A. Zernecke, E. Shagdarsuren, and C. Weber Chemokines in atherosclerosis: an update Arterioscler. Thromb. Vasc. Biol. 28 2008 1897 1908
44. Y.P. Zhou, K. Marlen, J.F. Palma, A. Schweitzer, L. Reilly, F.M. Gregoire, G.G. Xu, J.E. Blume, and J.D. Johnson Overexpression of repressive cAMP response element modulators in high glucose and fatty acid-treated rat islets. A common mechanism for glucose toxicity and lipotoxicity? J. Biol. Chem. 278 2003 51316 51323